Lee M. Ocuin, MD, joined University Hospitals as a faculty surgeon in the Division of Surgical Oncology in April 2021. Specializing in hepatopancreatobiliary surgery, Dr. Ocuin is also a clinical assistant professor of surgery. He graduated cum laude from Brandeis University (Waltham, Massachusetts) in 2002, where he earned a Bachelor of Science in Biochemistry and Biology. He obtained his medical degree from Tufts University School of Medicine (Boston, Massachusetts) in 2006 and was elected to the Alpha Omega Alpha Honor Medical Society.
My primary clinical and research focus will include pancreatic malignancies, primary and metastatic liver cancer as well as biliary cancers, with additional clinical focus on chronic pancreatitis. I plan to grow and develop University Hospitals into a regional and national referral center. Specifically, I will be leading the implementation of a Hepatic Artery Infusion (HAI) Pump program for regional therapy of unresectable metastatic colorectal cancer and intrahepatic cholangiocarcinoma. In addition to the clinical relevance and benefit to these patients, a HAI program allows for translational research opportunities as the immune response to HAI therapy is not well defined. This potentially allows for research and development of regionally directed immunotherapy in addition to standard of care floxuridine.